Call us on+91-7807096339
Get a Quote

Welcome to Biozenta

Biozenta is the vertically integrated, one of the leading & fastest growing pharmaceutical & life sciences group of companies with its presence in various therapies like Oncology, Anti-cancer, Cytotoxic, Critical-care, Life-saving, General Injectables, Contrast Media Injectables, Oral Solids - Tablets & Capsules – including Ant-retrovirals (ARVs), External Preparations – Derma & Cosmetics & also vertically integrated for key Oncology Active Pharmaceutical Ingredients (API’s).

Biozenta, a very versatile, fast growing & dynamic organization, established in the year 2018 with a major emphasis to serve the humanity through quality medicines to live the vision “Human helping Human”

Firm believer in Research & Innovation, Biozenta has focused on very unique & innovative products in across the healthcare range. With the state-of-the-art multi-locational EU-GMP approvable facilities, WHO GMP & PICs approved, located in one of the strategic Pharmaceutical Industrial zone of UNA District of H.P., having ultra-modern & well-equipped infrastructure for various units as below:

  • Oncology Facility - dedicated, completely isolated & separate unit at UNA, H.P., covers all the major dosage forms in Oncology, Anti-cancer, Cytotoxic range - Liquid Injectables, Lyophilized Injectables, Pre-filled Syringes (PFS) & Oral Solids - Tablets and Capsules.
  • General Facility – st&-alone & separate unit at UNA, H.P., covering all major dosage forms of Liquid Injectables, Lyophilized Injectables, Pre-filled Syringes (PFS), Contrast Media Injectables & Oral Solids - Tablets and Capsules, including Antiretrovirals (ARVs) products.
  • External preparations - separate unit formed as “Biogracea Medicare” at UNA H.P., covering all Topical forms of Derma & Cosmetics such as Cream, Ointment, Gel, Lotion, Shampoo & Dusting powder, etc.
  • Active Pharmaceutical Ingredients Unit - dedicated Oncology, Anti-cancer, Cytotoxic API and Intermediates facility located at UNA, H.P. to make company self-sufficient & vertically integrated with focus on to improve the synthetic procedures, Quality & stability of the Raw materials.

Milestones:

2018

First
Milestone

Biozenta registered its company in Roorkee, Uttarakhand.

2019

Second
Milestone

Started its Oncology and Critical Care manufacturing Unit at UNA, H.P.

2021

Third
Milestone

Started manufacturing unit for General range Plant for Injectables, Lyophilized Injectables, PFS, Contrast Media and Oral Solids at UNA H.P.

2021

Fourth
Milestone

Established, "Biogracea Medicare", a c-GMP compliant manufacturing unit for “External Preparation Drugs and Cosmetics” at UNA, H. P.

2021

Fifth
Milestone

Started its unique RandD Lab with advanced technology for “MAB-development” (Monoclonal antibody) in Chandigarh.

2021

Sixth
Milestone

Started its corporate office at Mohali Punjab for Business Development Activities and Regulatory Support.

2023

Seventh
Milestone

Proudly received “PICs” approval for Oncology and General Range manufacturing Unit based at UNA, H.P.

2023

Eighth
Milestone

Inaugurated its new “Corporate office” as “Biozenta House” in Mumbai.

2023

Ninth
Milestone

Signed “Partnership deed with US partner for Biosimilar products” to be launched by 2024.

2023

Tenth
Milestone

Launching into the Domestic Marketing Division" at Mohali, 2023.

2023

Eleventh
Milestone

Inaugurated its new “Corporate office” as “Biozenta, USA”

Request A Call Back
Register Drug Shortage
Online Enquiry
Job Opportunities